2004 Annual Report
Total Page:16
File Type:pdf, Size:1020Kb
Annual Report 2004 PREVENTION INNOVATION DEDICATION Contents Prevention, Innovation, Dedication..............................................................................................................................................................................................1 Chairman’s message.............................................................................................................................................................................................................................2 Director’s report....................................................................................................................................................................................................................................4 Research Review 2004.......................................................................................................................................................................................................................6 Divisional highlights.................................................................................................................................................................................................................6 Aboriginal child health..........................................................................................................................................................................................................8 Asthma, allergies and respiratory diseases ............................................................................................................................................................10 Birth defects ............................................................................................................................................................................................................................12 Cancer and leukaemia .......................................................................................................................................................................................................14 Developmental disorders ................................................................................................................................................................................................16 Infectious diseases ................................................................................................................................................................................................................18 Mental health ..........................................................................................................................................................................................................................20 Perinatal epidemiology.......................................................................................................................................................................................................22 Senior staff..............................................................................................................................................................................................................................................24 Collaborations and joint ventures.............................................................................................................................................................................................27 Corporate partnerships..................................................................................................................................................................................................................28 Affiliated groups’ reports................................................................................................................................................................................................................29 Board of Directors.............................................................................................................................................................................................................................30 Management structure ....................................................................................................................................................................................................................32 Chief Financial Officer’s report...................................................................................................................................................................................................33 The year in brief..................................................................................................................................................................................................................................36 Research grant income....................................................................................................................................................................................................................37 Our supporters ...................................................................................................................................................................................................................................38 Our mission To improve and to promote the health and wellbeing of all children through the unique application of multidisciplinary research. Our aims To conduct high quality research. To apply research findings to improve the health of children, adolescents and families. To teach the next generation of health researchers. To be an advocate for research and for children. Prevention…. is our aim.While more effective treatments are important, how much better it would be if we could stop diseases, disorders and disabilities in their tracks, before they emerge to damage the life of a child. Sounds like a dream? Not to us.These problems are caused by a complex interaction between genetics and environmental factors. If we can map the routes that lead to disease, we can identify early opportunities to stop it. Innovation… is what happens when you bring together a critical mass of outstanding minds.The Institute’s collaborative, cross-disciplinary approach is at the cutting edge of medical research. Dedication… is what you get from the more than 400 people employed at the Telethon Institute who have committed themselves to improving the health and life chances of children, not just in Australia, but throughout the world.We know that it’s important work and we’re proud to be doing it. TELETHON INSTITUTE FOR CHILD HEALTH RESEARCH 2004 1 Chairman’s message We were proud to celebrate 2004 as the The Board is aware of some major challenges fifteenth year of research operations for our for the Institute at this stage of growth and Institute. Following some challenging early maturity. A comprehensive risk management years, the Telethon Institute for Child Health strategy is high on the list. As we prepare for Research is now recognised nationally, and the next five yearly review of the Institute in internationally, as a leader in child health and 2006, we are increasingly aware of the need to medical research. strategically plan and manage the next five The benefit-cost analysis undertaken for the years and beyond. Institute by the highly reputed Centre for A key to our success will be a review of and International Economics, and commissioned by renewed commitment to the purpose and the the Western Australian Office of Science and aims of the Institute and a clear articulation of Innovation, provided more than ample evidence the research programs to be undertaken. of the importance of our asthma and folate Growth of any kind must be sustained and research programs and of the work of the guided by the knowledge of the equipment and Institute overall. Compelling evidence of this other infrastructure resources that underpin a kind must be wonderfully reassuring to the successful research institute. governments, business corporations and many To succeed we must nurture our strategic members of the public of the economic and partnerships and alliances, at state, federal and social value in financially supporting this international levels. Our partners and allies Institute. themselves of course are carefully planning the For the first time in 2004, the Institute way ahead. By working together we can exceeded the $16 million mark for research achieve our mutual goals. income. National and international peer We are grateful for the support that we have reviewed competitive grants made up more received in many different ways from the than 50% of the total, with State and Federal Federal Government and from the State Government contracts and commercial Government.We acknowledge the mutually research contracts making up an important rewarding centre agreements with the balance. Our numbers now exceed 400 staff University of Western Australia, and with and students and the Board is very conscious Curtin University and we have strong that further growth must be carefully planned collaborations with other universities and and managed. research institutes. Underpinning the success of the staff in their As a member of the prestigious Australian research endeavours, has been the stability and Association of Medical Research Institutes we security provided by the Capital Investment are a member of a very strong family around Fund.This